Table 2.

Binary correlations between immune/inflammaotry parameters and cardiovascular risk inices in patients with non-affective psychoses

2a. All subjects
Subject Group	Parameter	Framingham Risk Score		Framingham General Cardiovascular Risk Score		Total : HDL Cholesterol Ratio
		ρ	p-value	ρ	p-value	ρ	p-value
Patients	WBC	0.12	0.24	0.12	0.22	0.15	0.14
	Neutrophils	0.09	0.35	0.11	0.27	0.03	0.74
	Lymphocytes	0.12	0.23	0.12	0.23	0.28	<0.01
	Monocytes	0.18	0.07	0.09	0.35	0.23	0.02
	hsCRP	0.06	0.55	0.23	0.02	0.16	0.10
Controls	WBC	0.08	0.60	0.07	0.67	0.22	0.16
	Neutrophils	0.24	0.14	0.26	0.10	0.31	0.05
	Lymphocytes	−0.28	0.08	−0.29	0.06	−0.05	0.76
	Monocytes	0.01	0.95	−0.04	0.82	0.07	0.66
	hsCRP	0.15	0.34	0.30	0.06	0.23	0.14

2b. Males
Subject Group	Parameter	Framingham Risk Score		Framingham General Cardiovascular Risk Score		Total : HDL Cholesterol Ratio
		ρ	p-value	ρ	p-value	ρ	p-value
Patients	WBC	0.26	0.05	0.27	0.04	0.42	<0.01
	Neutrophils	0.26	0.05	0.28	0.03	0.24	0.07
	Lymphocytes	0.14	0.29	0.13	0.33	0.49	<0.01
	Monocytes	0.21	0.12	0.17	0.20	0.49	<0.01
	hsCRP	0.20	0.13	0.26	0.05	0.23	0.08
Controls	WBC	0.22	0.39	0.49	0.04	0.60	0.01
	Neutrophils	0.26	0.30	0.51	0.03	0.46	0.06
	Lymphocytes	−0.39	0.11	−0.18	0.47	0.48	0.04
	Monocytes	0.21	0.41	0.36	0.14	0.27	0.29
	hsCRP	−0.02	0.93	0.20	0.44	0.21	0.41

2c. Females
Subject Group	Parameter	Framingham Risk Score		Framingham General Cardiovascular Risk Score		Total : HDL Cholesterol Ratio
		ρ	p-value	ρ	p-value	ρ	p-value
Patients	WBC	−0.10	0.50	−0.08	0.59	−0.13	0.39
	Neutrophils	−0.15	0.33	−0.11	0.49	−0.21	0.17
	Lymphocytes	0.13	0.39	0.10	0.53	0.01	0.98
	Monocytes	0.10	0.51	−0.06	0.72	−0.08	0.61
	hsCRP	0.03	0.87	0.23	0.13	0.10	0.53
Controls	WBC	−0.13	0.57	−0.21	0.34	−0.06	0.77
	Neutrophils	0.10	0.66	0.05	0.83	0.08	0.70
	Lymphocytes	−0.29	0.18	−0.34	0.12	−0.29	0.18
	Monocytes	−0.26	0.24	−0.34	0.11	−0.04	0.85
	hsCRP	0.29	0.18	0.37	0.08	0.03	0.88